{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:42:53Z","timestamp":1794966173955,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"German Center for Infection Research (DZIF) Academy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"German Center for Infection Research (DZIF)","doi-asserted-by":"publisher","award":["05.704"],"award-info":[{"award-number":["05.704"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"German Center for Infection Research (DZIF)","doi-asserted-by":"publisher","award":["05.807"],"award-info":[{"award-number":["05.807"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.antiviral.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T13:35:19Z","timestamp":1555853719000},"page":"146-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The retinoic acid receptor (RAR) \u03b1-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA"],"prefix":"10.1016","volume":"168","author":[{"given":"Shirin","family":"Nkongolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-0342","authenticated-orcid":false,"given":"Lea","family":"Nu\u00dfbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian A.","family":"Lempp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4764-1708","authenticated-orcid":false,"given":"Harald","family":"Wodrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1560-8038","authenticated-orcid":false,"given":"Stephan","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.04.009_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.clinre.2011.01.001","article-title":"Role of nuclear receptors in hepatitis B and C infections","volume":"35","author":"Andr\u00e9","year":"2011","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib2","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2016.02.008","article-title":"Intracellular transport and egress of hepatitis B virus","volume":"64","author":"Blondot","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib3","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1107\/S0907444999011026","article-title":"Structures of cellular retinoic acid binding proteins I and II in complex with synthetic retinoids","volume":"55","author":"Chaudhuri","year":"1999","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.antiviral.2019.04.009_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrm3932","article-title":"Mechanisms of retinoic acid signalling and its roles in organ and limb development","volume":"16","author":"Cunningham","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc56 complex as a host restriction factor","volume":"531","author":"Decorsi\u00e8re","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.04.009_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-15338-0","article-title":"Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP","volume":"7","author":"Donkers","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.04.009_bib7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cell.2008.09.002","article-title":"Retinoic acid synthesis and signaling during early organogenesis","volume":"134","author":"Duester","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.04.009_bib8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/330624a0","article-title":"Identification of a receptor for the morphogen retinoic acid","volume":"330","author":"Giguere","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.04.009_bib9","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/JVI.79.3.1613-1622.2005","article-title":"Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein","volume":"79","author":"Gripon","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib10","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2019.04.009_bib11","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1128\/JVI.76.8.3709-3719.2002","article-title":"Parameters of human hepatitis delta virus genome replication: the quantity , quality , and intracellular distribution of viral proteins and RNA","volume":"76","author":"Gudima","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ja.2009.87","article-title":"Synthesis , structures and anti-HBV activities of derivatives of the glutarimide antibiotic cycloheximide","volume":"62","author":"Guo","year":"2009","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.antiviral.2019.04.009_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/JVI.69.1.547-551.1995","article-title":"Retinoid X receptor \u03b1 transactivates the hepatitis B virus enhancer 1 element by forming a heterodimeric complex with the peroxisome proliferator-activated receptor","volume":"69","author":"Huan","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib14","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0168-8278(05)80419-2","article-title":"Regulation of hepatitis B virus gene expression","volume":"17","author":"Huan","year":"1993","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12072-013-9459-7","article-title":"An open-label phase I\/II study of tamibarotene in patients with advanced hepatocellular carcinoma","volume":"8","author":"Kanai","year":"2014","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.antiviral.2019.04.009_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2013.02.001","article-title":"Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system","volume":"98","author":"Lamontagne","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.04.009_bib17","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1473-3099(15)00155-3","article-title":"The prenylation inhibitor, lonafarnib: a new therapeutic strategy against hepatitis delta","volume":"15","author":"Ledgerwood","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.04.009_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jhep.2015.10.030","article-title":"Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor","volume":"64","author":"Lempp","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10211-2","article-title":"Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation","author":"Lempp","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2019.04.009_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00465-18","article-title":"Identification of retinoic acid receptor agonists as potent hepatitis B virus inhibitors via a drug repurposing screen","volume":"62","author":"Li","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.04.009_bib20","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2019.04.009_bib21","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2019.04.009_bib22","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1128\/JVI.02528-09","article-title":"The pre-S2 domain of the hepatitis B virus is dispensable for infectivity but serves a spacer function for L-protein-connected virus assembly","volume":"84","author":"Ni","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib23","series-title":"Hepatitis B Virus: Methods and Protocols, Methods in Molecular Biology","first-page":"15","article-title":"Hepatitis B virus infection of HepaRG cells, HepaRG-hNTCP cells, and primary human hepatocytes","author":"Ni","year":"2017"},{"key":"10.1016\/j.antiviral.2019.04.009_bib24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/330444a0","article-title":"A\u00a0human retinoic acid receptor which belongs to the family of nuclear receptors","volume":"330","author":"Petkovich","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.04.009_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","article-title":"Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones","volume":"130","author":"Pollicino","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2019.04.009_bib26","doi-asserted-by":"crossref","first-page":"20303","DOI":"10.1073\/pnas.0807740105","article-title":"Retinoic acid-gated sequence-specific translational control by RAR\u03b1","volume":"105","author":"Poon","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2019.04.009_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01117-18","article-title":"T5 exonuclease hydrolysis of Hepatitis B Virus replicative intermediates allows reliable quantification and fast drug efficacy testing of covalently closed circular DNA by PCR","author":"Qu","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","article-title":"Control of hepatitis B virus at the level of transcription","volume":"17","author":"Quasdorff","year":"2010","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.antiviral.2019.04.009_bib29","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1096\/fj.201500134","article-title":"Reciprocal regulation of farnesoid X receptor a activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes","volume":"30","author":"Radreau","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.antiviral.2019.04.009_bib30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/JVI.01562-12","article-title":"Independent activation of hepatitis B virus biosynthesis by retinoids, peroxisome proliferators, and bile acids","volume":"87","author":"Reese","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib31","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/JVI.01902-09","article-title":"Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction","volume":"84","author":"Schulze","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib32","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection\u202f: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.04.009_bib33","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.04.009_bib34","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1200\/JCO.2013.53.3570","article-title":"Tamibarotene as maintenance therapy for acute promyelocytic Leukemia\u202f: results from a randomized controlled trial","volume":"32","author":"Shinagawa","year":"2014","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01771-17","article-title":"Silencing retinoid X receptor alpha expression enhances early-stage hepatitis B virus infection in cell cultures","author":"Song","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib36","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013","volume":"388","author":"Stanaway","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.04.009_bib37","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1128\/JVI.68.6.4063-4066.1994","article-title":"The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus","volume":"68","author":"Sureau","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib38","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood.V90.3.967","article-title":"Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid","volume":"90","author":"Tobita","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2019.04.009_bib39","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1074\/jbc.M114.602540","article-title":"Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression","volume":"290","author":"Tsukuda","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.04.009_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.gastro.2014.04.030","article-title":"Strategies to inhibit entry of HBV and HDV into hepatocytes","volume":"147","author":"Urban","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2019.04.009_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1525-1594.2007.00524.x","article-title":"Isolation of primary human hepatocytes after partial Hepatectomy\u202f: criteria for identification of the most promising liver specimen","volume":"32","author":"Vondran","year":"2007","journal-title":"Artif. Organs"},{"key":"10.1016\/j.antiviral.2019.04.009_bib42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2016.10.009","article-title":"Human stem cell-derived hepatocytes as a model for hepatitis B virus infection , spreading and virus-host interactions","volume":"66","author":"Xia","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2019.04.009_bib43","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218307587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218307587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:05:01Z","timestamp":1607299501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218307587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":44,"alternative-id":["S0166354218307587"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.04.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The retinoic acid receptor (RAR) \u03b1-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}